A phase I/II clinical study for an oral formulation of Belinostat
Phase of Trial: Phase I/II
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Belinostat (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Sep 2017 According to an Onxeo SA media release, the company expects to initiate this study in early 2019.
- 28 Apr 2017 New trial record
- 26 Apr 2017 According to an Onxeo SA media release, the company is planning to initiate this trial at the end of 2017.